Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection

Abstract The effectiveness of COVID-19 vaccination in children and adolescents with prior SARS-CoV-2 infection remains unclear, particularly for Omicron subvariants. We evaluate vaccine effectiveness against reinfection with Omicron BA.1/BA.2, BA.4/BA.5, XBB, and later subvariants among 5- to 17-yea...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yuqing Lei, Jiajie Chen, Qiong Wu, Ting Zhou, Bingyu Zhang, Michael J. Becich, Yuriy Bisyuk, Saul Blecker, Elizabeth A. Chrischilles, Dimitri A. Christakis, Lindsay G. Cowell, Mollie R. Cummins, Soledad A. Fernandez, Daniel Fort, Sandy L. Gonzalez, Sharon J. Herring, Benjamin D. Horne, Carol Horowitz, Mei Liu, Susan Kim, Parsa Mirhaji, Abu Saleh Mohammad Mosa, Jennifer A. Muszynski, Catharine I. Paules, Alice I. Sato, Hayden T. Schwenk, Soumitra Sengupta, Srinivasan Suresh, Bradley W. Taylor, David A. Williams, Yongqun He, Jeffrey S. Morris, Ravi Jhaveri, Christopher B. Forrest, Yong Chen, On behalf of the RECOVER Consortium
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2026-04-01
סדרה:	Nature Communications
גישה מקוונת:	https://doi.org/10.1038/s41467-026-71820-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!